Pharma Mar SA (PHM1N) Income Statement
Pharma Mar SA Income Statement
Last quarter (Q2 2026), Pharma Mar SA's total revenue was $49.60M, a decrease of 12.04% from the same quarter last year. In Q2, Pharma Mar SA's net income was $-972.00K. See Pharma Mar SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 221.39M | $ 174.85M | $ 158.15M | $ 196.34M | $ 229.83M | |
| $ 209.13M | $ 166.67M | $ 148.54M | $ 182.70M | $ 213.39M | |
| $ 168.85M | $ 160.20M | $ 152.37M | $ 138.27M | $ 121.04M | |
| Depreciation and Amortization | $ 8.02M | $ 6.77M | $ 5.76M | $ 5.90M | $ 5.58M |
| $ 48.30M | $ 21.23M | $ 4.55M | $ 52.07M | $ 104.08M | |
| $ 40.28M | $ 6.47M | $ -3.83M | $ 44.07M | $ 92.45M | |
| $ 19.38M | $ 5.52M | $ 204.00K | $ -281.00K | $ -6.36M | |
| $ 59.65M | $ 11.98M | $ -3.62M | $ 43.79M | $ 95.13M | |
| $ 74.99M | $ 26.13M | $ 1.14M | $ 49.36M | $ 92.86M | |
| Per Share Metrics | |||||
| Basic EPS | $ 4.30 | $ 1.49 | $ 0.06 | $ 2.73 | $ 5.14 |
| Diluted EPS | $ 4.30 | $ 1.49 | $ 0.06 | $ 2.73 | $ 5.13 |
| Weighted Average Shares Outstanding | 17.21M | 17.54M | 17.90M | 18.05M | 18.07M |
| Weighted Average Shares Outstanding (Diluted) | 17.21M | 17.56M | 17.92M | 18.06M | 18.09M |
Currency in EUR